Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence.

Vu, Tuan; Wiendl, Heinz; Katsuno, Masahisa; Reddel, Stephen W; Howard, James F

Vu, Tuan; Wiendl, Heinz; Katsuno, Masahisa; Reddel, Stephen W; Howard, James F.

Afiliación

Vu T; Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Wiendl H; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Katsuno M; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Reddel SW; Department of Neurology, Concord Hospital, University of Sydney, Sydney, NSW, Australia.
Howard JF; Department of Neurology, The University of North Carolina, Chapel Hill, NC, USA.

Neuropsychiatr Dis Treat ; 19: 2639-2655, 2023.

Article en En | MEDLINE | ID: mdl-38059203

Palabras clave

acetylcholine receptor antibody; complement; membrane attack complex; monoclonal antibody; terminal complement complex

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neuropsychiatr Dis Treat Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google